Sanofi’s $9.5 Billion Blueprint Medicines Deal Shakes Up 2025 Immunology Landscape
Pharma Titans Collide: Sanofi Makes Massive $9.5 Billion Play for Blueprint Medicines to Dominate Rare Immunology Sanofi acquires Blueprint Medicines for $9.5B, boosting its rare immunology portfolio and accelerating game-changing…